Controversies in Gene Therapy Approval

This chapter examines the contentious approval of a gene therapy by a key FDA official, raising alarms about the potential health implications and the troubling lack of transparency. It emphasizes the erosion of trust in health authorities and critiques the broader trend of discouraging inquiry into vaccination policies amidst growing health concerns.